Patient registries have evolved from basic lists of people with specific medical conditions into complex databases that carefully monitor disease states and track outcomes of medical interventions. Today’s patient registries, whether disease-based, observational, or product-focused, are vital resources for capturing real-world patient information.
NERI patient registries achieve multiple scientific, commercial, and regulatory goals to provide:
- Much-needed information on the natural history of rare conditions
- Sources of potential patients for clinical trial participation, which can speed recruitment efforts
- Patient-reported outcomes, generalized findings, and tracking data
- Post-market surveillance to meet regulatory requirements of the Food and Drug Administration (FDA)
- Data to meet reimbursement requirements of the Centers for Medicare and Medicaid Services (CMS)
The expertise NERI brings in patient registry services results from our collaborative atmosphere which draws on epidemiologic, biostatistics, data management and other in house expertise. Our company size and structure allows us the flexibility to immediately address creation, coordination, analysis, and management of large, and often disparate, datasets. This also translates into decades of experience combining data from active registries and clinical trials into a single registry with ongoing patient follow-up for long-term safety and effectiveness.